Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2009 by Hospital Arnau de Vilanova.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Hospital Arnau de Vilanova
ClinicalTrials.gov Identifier:
NCT00905983
First received: May 19, 2009
Last updated: NA
Last verified: May 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2011
  Estimated Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)